Loading…
Enhancing Drug Safety and Innovation Act of 2007
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
82pct
41d open
vs 3,722 other S bills in the 110th — cohort avg 42d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (24)
Bills with similar content found using semantic analysis.
Sources: Congress.gov
2008 · second_quarter · Health Issues
1561/S 484 - A bill to amend the Public Health Service Act and the Federal Food, Drug and Cosmetic Act to improve drug safety and oversight [Seth Radus]. /// Other issues: Preemption and Import safety.
Client expense: $924,074 · Firm income: Not reported
Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Medicare Payment Advisory Commission (MedPAC), Patent & Trademark Office (PTO), SENATE, Small Business Administration (SBA), White House Office
2008 · third_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · third_quarter · Budget/Appropriations
S. 251 Pharmaceutical Market Access Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; S. 484 Enhancing Drug Safety and Innovation Act of 2007; H.R. 380 Pharmaceutical Market Access and Drug Safety Act of 2007; H.R. 788 Food and Drug Administration Safety Act of 2007; H.R. 2117 Health Freedom Protection Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Health Issues
H.R.1585, National Defense Authorization Act for Fiscal Year 2008; H.R.2638, Department of Homeland Security Appropriations Act, 2008; H.R.2900, Food and Drug Administration Amendments Act of 2007; H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; H.R.3162, Children's Health and Medicare Protection Act of 2007; H.R.4083, Non-prescription Drug Modernization Act od 2007; S.242, Pharmaceutical Market Access and Drug Safety Act of 2007; S.468, Food and Drug Administration Safety Act of 2007; S.484, Enhancing Drug Safety and Innovation Act of 2007; S.830, Pediatric Medical Device Safety and Improvement Act of 2007; S.993, Pediatric Research Improvement Act; S.1082, Food and Drug Administration Revitalization Act; S.1547, National Defense Authorization Act for Fiscal Year 2008; S.1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; S.2331, Non-prescription Drug Modernization Act of 2007; SConRes.21, Concurrent resolution setting forth the congressional budget for the United States. Legisaltive proposals to extend federal contract prices to the retail section in the TRICARE program: H.R.1585, National Defense Authorization Act for Fiscal Year 2008; S.1547, National Defense Authorization Act for Fiscal Year 2008. Legilsative proposals permitting importation of prescription drugs from overseas: H.R.2638, Department of Homeland Security Appropriations Act, 2008; H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; H.R.3162, Children's Health and Medicare Protection Act of 2007; S.242, Pharmaceutical Market Access and Drug Safety Act of 2007; S.1082, Food and Drug Administration Revitalization Act; S.1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; SConRes.21, Concurrent resolution setting forth the congressional budget for the United States. Legislative proposals regarding drug safety, clinical trial registries, DTC adverstising, and reauthorization of the Prescription Drug User Fee Act, Best Pharmaceuticals for Children Act and Pediatric Research Equity Act: H.R.2900, Food and Drug Administration Amendments Act of 2007; S.468, Food and Drug Administration Safety Act of 2007; S.484, Enhancing Drug Safety and Innovation Act of 2007; S.830, Pediatric Medical Device Safety and Improvement Act of 2007; S.993, Pediatric Research Improvement Act; S.1082, Food and Drug Administration Revitalization Act; S.1547, National Defense Authorization Act for Fiscal Year 2008. Legislative proposals regarding FDA funding: H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; S.1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008. Legislative proposals to ensure access to meth-safe alternative medicines: H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; S.1859, Agriculture, Rural Development , Food and Drug Administration, and Related Agencies Appropriations Act, 2008. Legislative propsals to reform the OTC monograph system: H.R.4083, Non-prescription Drug Modernization Act of 2007; S.2331, Non-prescription Drug Modernization Act of 2007. Response to congressional investigation regarding ENHANCE study.
2008 · fourth_quarter · Consumer Issues/Safety/Products
HR 780, Counterfeit Drug Prevention Act, pharmaceutical counterfeiting S 2699, Neglected Diseases Elimination Act, promote R&D S 484, Enhancing Drug Safety and Innovation Act 2006 S 1082, FDA Revitalization Act 3/07 HR 2900, FDA Amendments Act 2007 S. 242, Pharmaceutical Market Access and Drug Safety Act 3/07 HR. 380, Pharmaceutical Market Access and Drug Safety Act 2/07
Client expense: $3,250,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, Veterans Affairs, Dept of (VA)
Client expense: $520,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Medical/Disease Research/Clinical Labs
S. 3230 - Labor HHS appropriations S. 588; H.R. 1093 Residency Caps H.R. 3; S. 5; S. 30 Stem Cell S. 1576 Minority Improvent S. 1066 Medical Affordability Act H.R. 4854, S. 2041 False Claims Correction Act S. 484 Research Misconduct Clinical Trials The role of gene patents in research and genetic testing
Client expense: $110,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), SENATE, State, Dept of (DOS), Transportation, Dept of (DOT)
2008 · fourth_quarter · Pharmacy
H.R.970, the Dextromethorphan Distribution Act, as related to the abuse of dextromethorphan. H.R.971, the Community Pharmacy Fairness Act, as related to provider negotiations in the Medicare program. H.R.1424, the Emergency Economic Stabilization Act of 2008, as related to fiscal sustainablity of healthcare services. H.R.1474, the Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act, as related to provider reimbursement in the Medicare program. H.R.3700, the Fair Medicaid Drug Payment Act, as related to pharmacy reimbursement in the Medicaid program. H.R.5613, Protecting the Medicaid Safety Net Act of 2008, as related to provider participation in the Medicaid program. H.R.5839, Safeguarding America's Pharmaceuticals Act of 2008, as related to drug safety and electronic tracking of pharmaceuticals. H.R.6353/S.980, Ryan Haight Online Pharmacy Consumer Protection Act of 2008, as related to online pharmacies. H.R.6357, PRO(TECH)T Act of 2008, as related to pharmacy involvement in health information technology. H.R. 6898, the Health-e Information Technology Act of 2008 as related to pharmacy involvement in health information technology H.R. 7110, the Job Creation and Unemployment Relief Act of 2008, as related to increased funding for state Medicaid programs. S.484, the Enhancing Drug Safety and Innovation Act, all provisions related to the safety of prescription medicines. S. 1276, the Methamphetamine Production Prevention Act as related to recordkeeping requirements for pharmacies. S.1693, Wired for Health Care Quality Act, as related to health information technology. S.1827, Pharmacists Access and Recognition in Medicare (PhARM) Act, as related to provider participation in the Medicare program. S.1915, Electronic Prescribing Drug Act, as related to the regulation of electronic prescribing of pharmaceuticals. S.1951, the Fair Medicaid Drug Payment Act, as related to pharmacy reimbursement in the Medicaid program. S.1954, Pharmacy Access Improvement (PhAIm) Act, as related to access standards to pharmacies. S.2013/H.R.390, Patient and Pharmacy Protection Act, as related to prescription requirements in the Medicaid program. S.2071, Combat Methamphetamine Enhancement Act, as related to the distribution of legal substances used in the production of methamphetamine. S.2274, Dextromethorphan Abuse Reduction Act, as related to the abuse of dextromethorphan. S.2408/H.R.4296, Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007, as related to electronic health care in the Medicare program. S.3101/H.R.6331, Medicare Improvements for Patients and Providers Act of 2008, as related to pharmacy reimbursement in the Medicaid and Medicare programs and electronic health care. Various issues related to the disposal of prescription drugs and drug Take Back programs, no specific legislation
Client expense: $320,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Consumer Product Safety Commission (CPSC), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Natl Drug Control Policy (NDCP), SENATE, White House Office
2008 · fourth_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Health Issues
S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; H.R. 2823 Fair and Balanced Prescription Drug Advertisement Act of 2007
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; HR 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · third_quarter · Advertising
Legislation and regulations afecting the advertising, marketing and promotion of goods and services | Food Advertising | Prescription Drug Advertising | Children's Advertising | S.334 Healthy Americans Act | S.484 Enhancing Drug Safety and Innovation Act | S. 468 FDA Safety Act | HR 1561 Enhancing Drug Safety and Innovation Act | HR 2117 Health Freedom Protection Act | S 2311 Nonprescription Drug Modernization Act | S 100 Health Students Act | S 948 CAMRA Act |
Client expense: $75,000 · Firm income: Not reported
Government targets: Federal Communications Commission (FCC), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, SENATE
2008 · third_quarter · Consumer Issues/Safety/Products
HR 780, Counterfeit Drug Prevention Act, pharmaceutical counterfeiting S 2699, Neglected Diseases Elimination Act, promote R&D S 484, Enhancing Drug Safety and Innovation Act 2006 S 1082, FDA Revitalization Act 3/07 HR 2900, FDA Amendments Act 2007 S. 242, Pharmaceutical Market Access and Drug Safety Act 3/07 HR. 380, Pharmaceutical Market Access and Drug Safety Act 2/07
Client expense: $3,070,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, Veterans Affairs, Dept of (VA)
2008 · third_quarter · Health Issues
H.R.1585, National Defense Authorization Act for Fiscal Year 2008; H.R.2638, Department of Homeland Security Appropriations Act, 2008; H.R.2900, Food and Drug Administration Amendments Act of 2007; H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; H.R.3162, Children's Health and Medicare Protection Act of 2007; H.R.4083, Non-prescription Drug Modernization Act od 2007; S.242, Pharmaceutical Market Access and Drug Safety Act of 2007; S.468, Food and Drug Administration Safety Act of 2007; S.484, Enhancing Drug Safety and Innovation Act of 2007; S.830, Pediatric Medical Device Safety and Improvement Act of 2007; S.993, Pediatric Research Improvement Act; S.1082, Food and Drug Administration Revitalization Act; S.1547, National Defense Authorization Act for Fiscal Year 2008; S.1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; S.2331, Non-prescription Drug Modernization Act of 2007; SConRes.21, Concurrent resolution setting forth the congressional budget for the United States. Legisaltive proposals to extend federal contract prices to the retail section in the TRICARE program: H.R.1585, National Defense Authorization Act for Fiscal Year 2008; S.1547, National Defense Authorization Act for Fiscal Year 2008. Legilsative proposals permitting importation of prescription drugs from overseas: H.R.2638, Department of Homeland Security Appropriations Act, 2008; H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; H.R.3162, Children's Health and Medicare Protection Act of 2007; S.242, Pharmaceutical Market Access and Drug Safety Act of 2007; S.1082, Food and Drug Administration Revitalization Act; S.1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; SConRes.21, Concurrent resolution setting forth the congressional budget for the United States. Legislative proposals regarding drug safety, clinical trial registries, DTC adverstising, and reauthorization of the Prescription Drug User Fee Act, Best Pharmaceuticals for Children Act and Pediatric Research Equity Act: H.R.2900, Food and Drug Administration Amendments Act of 2007; S.468, Food and Drug Administration Safety Act of 2007; S.484, Enhancing Drug Safety and Innovation Act of 2007; S.830, Pediatric Medical Device Safety and Improvement Act of 2007; S.993, Pediatric Research Improvement Act; S.1082, Food and Drug Administration Revitalization Act; S.1547, National Defense Authorization Act for Fiscal Year 2008. Legislative proposals regarding FDA funding: H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; S.1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008. Legislative proposals to ensure access to meth-safe alternative medicines: H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; S.1859, Agriculture, Rural Development , Food and Drug Administration, and Related Agencies Appropriations Act, 2008. Legislative propsals to reform the OTC monograph system: H.R.4083, Non-prescription Drug Modernization Act of 2007; S.2331, Non-prescription Drug Modernization Act of 2007. Response to congressional investigation regarding ENHANCE study.
Client expense: $500,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · third_quarter · Medical/Disease Research/Clinical Labs
S. 3230 - Labor HHS appropriations S. 588; H.R. 1093 Residency Caps H.R. 3; S. 5; S. 30 Stem Cell S. 1576 Minority Improvent S. 1066 Medical Affordability Act H.R. 4854, S. 2041 False Claims Correction Act S. 484 Research Misconduct Clinical Trials The role of gene patents in research and genetic testing
Client expense: $110,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), SENATE, State, Dept of (DOS), Transportation, Dept of (DOT)
2008 · third_quarter · Consumer Issues/Safety/Products
HR 780, Counterfeit Drug Prevention Act, pharmaceutical counterfeiting S 2699, Neglected Diseases Elimination Act, promote R&D S 484, Enhancing Drug Safety and Innovation Act 2006 S 1082, FDA Revitalization Act 3/07 HR 2900, FDA Amendments Act 2007 S. 242, Pharmaceutical Market Access and Drug Safety Act 3/07 HR. 380, Pharmaceutical Market Access and Drug Safety Act 2/07
Client expense: $3,060,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, Veterans Affairs, Dept of (VA)
2008 · third_quarter · Health Issues
Generic Biologics H.R.1038/S.623: Access to Life-Saving Medicine Act S.1695: Biologics Price Competition and Innovation Act of 2007 H.R.5629: Pathway for Biosimiliars Act Citizen Petitions S.1088: Lower PRICED Drugs Act Drug Safety S.484: Enhancing Drug Safety and Innovation Act of 2007 H.R.5839: Safeguarding America's Pharmaceuticals Act of 2008 H.R. 3610: Food and Drug Import Safety Act of 2007 S. 3409: Drug and Device Accountability Act of 2008 Authorized Generics H.R.806: To amend the Federal Food, Drug and Cosmetic Act to prohibit the marketing of authorized generic drugs Generic substitution state come-out laws
Client expense: Not reported · Firm income: $60,000
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2008 · third_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · third_quarter · Health Issues
S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; H.R. 2823 Fair and Balanced Prescription Drug Advertisement Act of 2007
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · third_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · third_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · third_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · third_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · third_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · third_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · third_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · third_quarter · Pharmacy
See addendum. H.R.970, the Dextromethorphan Distribution Act, as related to the abuse of dextromethorphan. H.R.971, the Community Pharmacy Fairness Act, as related to provider negotiations in the Medicare program. H.R.1108, Family Smoking Prevention and Tobacco Control Act, as related to the regulation of the sale of tobacco products. H.R.1424, the Emergency Economic Stabilization Act of 2008, as related to fiscal sustainablity for healthcare services. H.R.1474, the Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act, as related to provider reimbursement in the Medicare program. H.R.3700, the Fair Medicaid Drug Payment Act, as related to pharmacy reimbursement in the Medicaid program. H.R.4008, Credit and Debit Card Receipt Clarification Act of 2007, as related to fair credit card practices. H.R.5491, Emilys Act, as related to the certification of pharmacy technicians. H.R.5546, Credit Card Fair Fee Act of 2008, as related to fair credit card practices. H.R.5613, Protecting the Medicaid Safety Net Act of 2008, as related to provider participation in the Medicaid program. H.R.5658, Duncan Hunter National Defense Authorization Act for Fiscal Year 2009, as related to provider participation in the TRICARE program. H.R.5839, Safeguarding America's Pharmaceuticals Act of 2008, as related to drug safety and electronic tracking of pharmaceuticals. H.R.6353/S.980, Ryan Haight Online Pharmacy Consumer Protection Act of 2008, as related to online pharmacies. H.R.6357, PRO(TECH)T Act of 2008, as related to pharmacy involvement in health information technology. H.R. 6491/S.3434, the Organized Retail Crime Act of 2008, as related to the prosecution of organized theft. H.R. 6713, the E-Fencing Enforcement Act of 2008, as related to the prosecution of organized theft. H.R. 6831/S.3666, the Copper Theft Prevention Act of 2008 as related to theft and interstate fencing of stolen copper. H.R. 6898, the Health-e Information Technology Act of 2008 as related to pharmacy involvement in health information technology H.R. 7110, the Job Creation and Unemployment Relief Act of 2008, as related to increased funding for state Medicaid programs. S.484, the Enhancing Drug Safety and Innovation Act, all provisions related to the safety of prescription medicines. S. 1276, the Methamphetamine Production Prevention Act as related to recordkeeping requirements for pharmacies. S.1693, Wired for Health Care Quality Act, as related to health information technology. S.1827, Pharmacists Access and Recognition in Medicare (PhARM) Act, as related to provider participation in the Medicare program. S.1915, Electronic Prescribing Drug Act, as related to the regulation of electronic prescribing of pharmaceuticals. S.1951, the Fair Medicaid Drug Payment Act, as related to pharmacy reimbursement in the Medicaid program. S.1954, Pharmacy Access Improvement (PhAIm) Act, as related to access standards to pharmacies. S.2013/H.R.390, Patient and Pharmacy Protection Act, as related to prescription requirements in the Medicaid program. S.2071, Combat Methamphetamine Enhancement Act, as related to the distribution of legal substances used in the production of methamphetamine. S.2274, Dextromethorphan Abuse Reduction Act, as related to the abuse of dextromethorphan. S.2408/H.R.4296, Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007, as related to electronic health care in the Medicare program. S.2978, Credit and Debit Card Receipt Clarification Act of 2008, as related to fair credit card practices S.3001, National Defense Authorization Act for Fiscal Year 2009, as related to provider participation in the TRICARE program. S.3086, Credit Card Fair Fee Act of 2008, as related to fair credit card practices. S.3101/H.R.6331, Medicare Improvements for Patients and Providers Act of 2008, as related to pharmacy reimbursement in the Medicaid and Medicare programs and electronic health care.
Client expense: $300,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Office of Natl Drug Control Policy (NDCP), President of the U.S., SENATE
2008 · second_quarter · Consumer Issues/Safety/Products
HR 780, Counterfeit Drug Prevention Act, pharmaceutical counterfeiting S 2699, Neglected Diseases Elimination Act, promote R&D S 484, Enhancing Drug Safety and Innovation Act 2006 S 1082, FDA Revitalization Act 3/07 HR 2900, FDA Amendments Act 2007 S. 242, Pharmaceutical Market Access and Drug Safety Act 3/07 HR. 380, Pharmaceutical Market Access and Drug Safety Act 2/07
Client expense: $3,060,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, Veterans Affairs, Dept of (VA)
2008 · second_quarter · Health Issues
H.R.1585, National Defense Authorization Act for Fiscal Year 2008; H.R.2638, Department of Homeland Security Appropriations Act, 2008; H.R.2900, Food and Drug Administration Amendments Act of 2007; H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; H.R.3162, Children's Health and Medicare Protection Act of 2007; H.R.4083, Non-prescription Drug Modernization Act od 2007; S.242, Pharmaceutical Market Access and Drug Safety Act of 2007; S.468, Food and Drug Administration Safety Act of 2007; S.484, Enhancing Drug Safety and Innovation Act of 2007; S.830, Pediatric Medical Device Safety and Improvement Act of 2007; S.993, Pediatric Research Improvement Act; S.1082, Food and Drug Administration Revitalization Act; S.1547, National Defense Authorization Act for Fiscal Year 2008; S.1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; S.2331, Non-prescription Drug Modernization Act of 2007; SConRes.21, Concurrent resolution setting forth the congressional budget for the United States. Legisaltive proposals to extend federal contract prices to the retail section in the TRICARE program: H.R.1585, National Defense Authorization Act for Fiscal Year 2008; S.1547, National Defense Authorization Act for Fiscal Year 2008. Legilsative proposals permitting importation of prescription drugs from overseas: H.R.2638, Department of Homeland Security Appropriations Act, 2008; H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; H.R.3162, Children's Health and Medicare Protection Act of 2007; S.242, Pharmaceutical Market Access and Drug Safety Act of 2007; S.1082, Food and Drug Administration Revitalization Act; S.1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; SConRes.21, Concurrent resolution setting forth the congressional budget for the United States. Legislative proposals regarding drug safety, clinical trial registries, DTC adverstising, and reauthorization of the Prescription Drug User Fee Act, Best Pharmaceuticals for Children Act and Pediatric Research Equity Act: H.R.2900, Food and Drug Administration Amendments Act of 2007; S.468, Food and Drug Administration Safety Act of 2007; S.484, Enhancing Drug Safety and Innovation Act of 2007; S.830, Pediatric Medical Device Safety and Improvement Act of 2007; S.993, Pediatric Research Improvement Act; S.1082, Food and Drug Administration Revitalization Act; S.1547, National Defense Authorization Act for Fiscal Year 2008. Legislative proposals regarding FDA funding: H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; S.1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008. Legislative proposals to ensure access to meth-safe alternative medicines: H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; S.1859, Agriculture, Rural Development , Food and Drug Administration, and Related Agencies Appropriations Act, 2008. Legislative propsals to reform the OTC monograph system: H.R.4083, Non-prescription Drug Modernization Act of 2007; S.2331, Non-prescription Drug Modernization Act of 2007. Response to congressional investigation regarding ENHANCE study.
Client expense: $530,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · second_quarter · Advertising
Food Advertising; Prescription Drug Advertising; Children's Advertising; S.334 Healthy Americans Act; S.484 Enhancing Drug Safety and Innovation Act of 2007; S.468 Food and Drug Administration Safety Act of 2007; HR 1561 Enhancing Drug Safety and Innovation Act of 2007; HR 2117 Health Freedom Protection Act; S 2311 Nonprescription Drug Modernization Act; HR 4083 Nonprescription Drug Modernization Act; S 100 Healthy Students Act of 2007; S 948 CAMRA Act; S. 1031; HR 2045; HR 2633;
Client expense: $75,000 · Firm income: Not reported
Government targets: Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, SENATE
2008 · second_quarter · Health Issues
1561/S 484 - A bill to amend the Public Health Service Act and the Federal Food, Drug and Cosmetic Act to improve drug safety and oversight [Seth Radus]. /// Other issues: Preemption and Import safety.
Client expense: $924,074 · Firm income: Not reported
Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Medicare Payment Advisory Commission (MedPAC), Patent & Trademark Office (PTO), SENATE, Small Business Administration (SBA), White House Office
2008 · second_quarter · Medical/Disease Research/Clinical Labs
H.R. 3043; S. 1710 - Labor HHS appropriations S. 588; H.R. 1093 Residency Caps H.R. 3; S. 5; S. 30 Stem Cell S. 1576 Minority Improvent S. 1066 Medical Affordability Act H.R. 4854, S. 2041 False Claims Correction Act S. 484 Research Misconduct Clinical Trials
Client expense: $110,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), SENATE, State, Dept of (DOS), Transportation, Dept of (DOT)
2008 · second_quarter · Health Issues
Generic Biologics S.623: Access to Life-Saving Medicine Act S.1695: Biologics Price Competition and Innovation Act of 2007 H.R.5629: Pathway for Biosimiliars Act Citizen Petitions S.1088: Lower PRICED Drugs Act Drug Safety S.484: Enhancing Drug Safety and Innovation Act of 2007 H.R.5839: Safeguarding America's Pharmaceuticals Act of 2008 Authorized Generics H.R.806: To amend the Federal Food, Drug and Cosmetic Act to prohibit the marketing of authorized generic drugs
Client expense: Not reported · Firm income: $60,000
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2008 · second_quarter · Pharmacy
See addendum. H.R.970, the Dextromethorphan Distribution Act, as related to the abuse of dextromethorphan. H.R.971, the Community Pharmacy Fairness Act, as related to provider negotiations in the Medicare program. H.R.1038/S.623, Access to Life-Saving Medicine Act, as related to the approval of generic biopharmaceuticals. H.R.1108, Family Smoking Prevention and Tobacco Control Act, as related to the regulation of the sale of tobacco products. H.R.1474, the Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act, as related to provider reimbursement in the Medicare program. H.R.3140, Saving Our Community Pharmacies Act, as related to Medicaid provider reimbursement. H.R.3193, Access to Community Pharmacy Preservation Act, as related to Medicaid provider reimbursement. H.R.3700, the Fair Medicaid Drug Payment Act, as related to pharmacy reimbursement in the Medicaid program. H.R.4008, Credit and Debit Card Receipt Clarification Act of 2007, as related to fair credit card practices. H.R.5491, Emilys Act, as related to the certification of pharmacy technicians. H.R.5546, Credit Card Fair Fee Act of 2008, as related to fair credit card practices. H.R.5613, Protecting the Medicaid Safety Net Act of 2008, as related to provider participation in the Medicaid program. H.R.5629, Pathway for Biosimilars Act, as related to the availability of generic pharmaceuticals. H.R.5658, Duncan Hunter National Defense Authorization Act for Fiscal Year 2009, as related to provider participation in the TRICARE program. H.R.5839, Safeguarding America's Pharmaceuticals Act of 2008, as related to drug safety and electronic tracking of pharmaceuticals. H.R.6252, Medicare DMEPOS Competitive Acquisition Reform Act of 2008, as related to provider participation in the Medicare competitive bidding program. H.R.6331, the Medicare Improvements for Patients and Providers Act of 2008, as related to pharmacy reimbursement, electronic health care, and Medicare programs. H.R.6353, Ryan Haight Online Pharmacy Consumer Protection Act of 2008, as related to online pharmacies. H.R.6357, PRO(TECH)T Act of 2008, as related to health information technology. S.484, the Enhancing Drug Safety and Innovation Act, all provisions related to the safety of prescription medicines. S.980, Ryan Haight Online Pharmacy Consumer Protection Act of 2008, as related to online pharmacies. S.1693, Wired for Health Care Quality Act, as related to health information technology. S.1695, the Biologics Price Competition and Innovation Act, as related to the approval of generic biopharmaceuticals. S.1827, Pharmacists Access and Recognition in Medicare (PhARM) Act, as related to provider participation in the Medicare program. S.1915, Electronic Prescribing Drug Act, as related to the regulation of electronic prescribing of pharmaceuticals. S.1951, the Fair Medicaid Drug Payment Act, as related to pharmacy reimbursement in the Medicaid program. S.1954, Pharmacy Access Improvement (PhAIm) Act, as related to access standards to pharmacies. S.2013/H.R.390, Patient and Pharmacy Protection Act, as related to prescription requirements in the Medicaid program. S.2071, Combat Methamphetamine Enhancement Act, as related to the distributio of legal substances used in the production of methamphetamine. S.2274, Dextromethorphan Abuse Reduction Act, as related to the abuse of dextromethorphan. S.2408/H.R.4296, Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007, as related to electronic health care in the Medicare program. S.2978, Credit and Debit Card Receipt Clarification Act of 2008, as related to fair credit card practices S.3001, National Defense Authorization Act for Fiscal Year 2009, as related to provider participation in the TRICARE program. S.3086, Credit Card Fair Fee Act of 2008, as related to fair credit card practices. S.3101, Medicare Improvements for Patients and Providers Act of 2008, as related to pharmacy reimbursement and electronic health care.
Client expense: $420,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Office of Natl Drug Control Policy (NDCP), President of the U.S., SENATE
2008 · second_quarter · Health Issues
S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; H.R. 2823 Fair and Balanced Prescription Drug Advertisement Act of 2007
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · second_quarter · Budget/Appropriations
S. 251 Pharmaceutical Market Access Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; S. 484 Enhancing Drug Safety and Innovation Act of 2007; H.R. 380 Pharmaceutical Market Access and Drug Safety Act of 2007; H.R. 788 Food and Drug Administration Safety Act of 2007; H.R. 2117 Health Freedom Protection Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · second_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · second_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · second_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · second_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · second_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · second_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · second_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE